AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie oPEB Obligation Weighted-Average Discount Rate (%) (%)
Form 10-K Note 12 Post-Employment Benefits
Latest, FY2025
5.6%
Period ended Dec 31, 2025
Change on a year earlier
-0.1 pts
5.7% in FY2024
History
10 years
Since FY2016
Sources
9
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | OPEB Obligation Weighted-Average Discount Rate (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5.6% | -0.1 pts | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 5.7% | +0.6 pts | Form 10-K (filed 2026-02-20) ↗ |
| FY2023 | Dec 31, 2023 | 5.1% | -0.2 pts | Form 10-K (filed 2025-02-14) ↗ |
| FY2022 | Dec 31, 2022 | 5.3% | +2.2 pts | Form 10-K (filed 2024-02-20) ↗ |
| FY2021 | Dec 31, 2021 | 3.1% | +0.3 pts | Form 10-K (filed 2023-02-17) ↗ |
| FY2020 | Dec 31, 2020 | 2.8% | -0.8 pts | Form 10-K (filed 2022-02-18) ↗ |
| FY2019 | Dec 31, 2019 | 3.6% | -1.0 pts | Form 10-K (filed 2021-02-19) ↗ |
| FY2018 | Dec 31, 2018 | 4.6% | +0.7 pts | Form 10-K (filed 2020-02-21) ↗ |
| FY2017 | Dec 31, 2017 | 3.9% | -0.8 pts | Form 10-K (filed 2019-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 4.7% | – | Form 10-K (filed 2018-02-16) ↗ |
Cite this data
StockData. (2026). AbbVie OPEB Obligation Weighted-Average Discount Rate (%) (%), annual FY2016–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/db_opeb_disc_rate
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.